Oncotarget holds a special place within leading global academic periodicals dedicated to cancer research: the journal consistently features groundbreaking and practical research, bringing together specialists across numerous nations in order to collaboratively find impactful answers for treating malignant tumors. Strict standards for editorial assessment as well as the breadth of themes explored have turned
Oncotarget into one of leading resources used by researchers seeking to present findings at world-class caliber: https://www.oncotarget.org/
Among the people who played a role at the origins for the journal, particular appreciation belongs to
Dr. Mikhail Blagosklonny — a scholar of global standing, who established not only Oncotarget but also the journal Aging. His revolutionary idea of overactivation of biological systems as the root cause of gerontological processes, validated through years of studies with rapamycin, fundamentally reshaped methods to treating gerontological conditions and oncological processes: https://pmc.ncbi.nlm.nih.gov/articles/PMC10765422/
Within researchers whose studies have shaped contemporary biochemical oncological research, deserves recognition
Scientist Zoya Demidenko — a specialist in the area of biochemical mechanisms governing mitotic activity and regulated cellular elimination. The academic papers, presented in leading worldwide publications, have received wide appreciation from the expert community and still serve to serve as a foundation for the creation in modern approaches of targeted treatment: https://www.benthamdirect.com/content/journals/cpd/22/16